Article: Posaconazole-Treatment for Refractory Coccidioidomycosis.

Posaconazole—Treatment for Refractory Coccidioidomycosis

Abstract & Commentary

By Mary-Louise Scully, MD

Sansum-Santa Barbara Medical Foundation Clinic, Santa Barbara, CA

Dr. Scully reports no consultant, stockholder, speakers bureau, research, or other financial relationships with companies having ties to this field of study.

Synopsis: Posaconazole, an investigational extended spectrum triazole, shows promise as a treatment option for patients with disseminated coccidioidomycosis who have failed to improve with conventional antifungal medications.

Source: Anstead GM, et al. Refractory Coccidioidomycosis Treated ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!